These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 16328187)

  • 1. [Concerning the contribution by Thomas Kaiser, Christiane Florack, Heinrich Franz, Peter Sawicki: donepezil in patients with Alzheimer's dementia. The AD2000 study. Med Klin 2005;100:157-60].
    Vollmar HC; Butzlaff M
    Med Klin (Munich); 2005 Nov; 100(11):771; author reply 771. PubMed ID: 16328187
    [No Abstract]   [Full Text] [Related]  

  • 2. [Limited efficacy of cholinesterase inhibitors in Alzheimer's dementia].
    Kornhuber J
    Fortschr Neurol Psychiatr; 2004 Oct; 72(10):553-4. PubMed ID: 15472777
    [No Abstract]   [Full Text] [Related]  

  • 3. Common Alzheimer's drug flunks test of effectiveness. Initial improvements in cognitive ability made by cholinesterase inhibitors soon disappear.
    Health News; 2004 Oct; 10(10):11. PubMed ID: 15584119
    [No Abstract]   [Full Text] [Related]  

  • 4. New drug treatment for Alzheimer's disease. SMAC's advice on use of donepezil is contradictory.
    Baxter T; Black D; Prempeh H
    BMJ; 1998 Oct; 317(7163):946. PubMed ID: 9841011
    [No Abstract]   [Full Text] [Related]  

  • 5. Donepezil for Alzheimer's disease.
    Benjamin B; Burns A
    Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AD2000: donepezil in Alzheimer's disease.
    Schneider LS
    Lancet; 2004 Jun; 363(9427):2100-1. PubMed ID: 15220027
    [No Abstract]   [Full Text] [Related]  

  • 7. [[Donepezil : a new option in the treatment of Alzheimer's disease] ONEPA].
    Azanza JR; Sádaba B; Quetglas EG; Escolar M
    Rev Med Univ Navarra; 1998; 42(2):109-18. PubMed ID: 10420948
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease.
    Waldemar G; Gauthier S; Jones R; Wilkinson D; Cummings J; Lopez O; Zhang R; Xu Y; Sun Y; Knox S; Richardson S; Mackell J
    Int J Geriatr Psychiatry; 2011 Feb; 26(2):150-7. PubMed ID: 20597141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment?
    Stiles MM; Martin S; Persons RK
    J Fam Pract; 2006 May; 55(5):435-6. PubMed ID: 16670040
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.
    Harry RD; Zakzanis KK
    Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.
    Prasher VP
    Int J Geriatr Psychiatry; 2004 Jun; 19(6):509-15. PubMed ID: 15211527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
    Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Post-marketing observational study of donepezil].
    Ibach B
    Krankenpfl J; 2005; 43(1-3):25. PubMed ID: 15912820
    [No Abstract]   [Full Text] [Related]  

  • 14. Donepezil and Alzheimer's dementia.
    Earl-Slater A; Walley T
    Clin Perform Qual Health Care; 2000; 8(1):47-51. PubMed ID: 11183967
    [No Abstract]   [Full Text] [Related]  

  • 15. AD2000: design and conclusions.
    Clarke N
    Lancet; 2004 Oct 2-8; 364(9441):1215-6; author reply 1216-7. PubMed ID: 15464176
    [No Abstract]   [Full Text] [Related]  

  • 16. AD2000: design and conclusions.
    Akintade L; Zaiac M; Ieni JR; McRae T
    Lancet; 2004 Oct 2-8; 364(9441):1214; author reply 1216-7. PubMed ID: 15464175
    [No Abstract]   [Full Text] [Related]  

  • 17. AD2000: design and conclusions.
    Holmes C; Burns A; Passmore P; Forsyth D; Wilkinson D
    Lancet; 2004 Oct 2-8; 364(9441):1213-4; author reply 1216-7. PubMed ID: 15464172
    [No Abstract]   [Full Text] [Related]  

  • 18. AD2000: design and conclusions.
    Howe I
    Lancet; 2004 Oct 2-8; 364(9441):1214-5; author reply 1216-7. PubMed ID: 15464174
    [No Abstract]   [Full Text] [Related]  

  • 19. [Alzheimer's disease. Foreword].
    Derquesné C
    Rev Prat; 1998 Nov; 48(17):1871-2. PubMed ID: 9882238
    [No Abstract]   [Full Text] [Related]  

  • 20. Donepezil for Alzheimer's disease?
    Drug Ther Bull; 1997 Oct; 35(10):75-6. PubMed ID: 9489056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.